SCHEMBL9828333

SCHEMBL9828333

CC(=O)Cn1ncc(-c2cccs2)nc1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
NPC1 O15118 4/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 1/20 0.42
ADORA2A P29274 4/20 0.41
ADORA3 P0DMS8 3/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 2/20 0.40
UBE2M P61081 1/20 0.40
DCUN1D1 Q96GG9 1/20 0.40
RAB9A P51151 5/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
ADORA1 P30542 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MITF O75030 1/20 0.40
S1PR4 O95977 1/20 0.40
S1PR1 P21453 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9829309 0.78 NPC1 (0.43) KDM4ENPC1HSD17B10ADORA3MEN1
SCHEMBL9831218 0.74 RAB9A (0.42) NPC1HSD17B10MAPK1KMT2AGAA
SCHEMBL9828830 0.74 ALDH1A1 (0.42) KDM4ENPC1HSD17B10MAPK1ADORA3
SCHEMBL9829103 0.72 ADORA3 (0.44) KDM4EHSD17B10ADORA2AADORA3USP2
SCHEMBL9828154 0.71 LMNA (0.46) NPC1HSD17B10ADORA3MEN1KMT2A
SCHEMBL9827533 0.69 NPC1 (0.46) KDM4ENPC1MAPK1ADORA3MEN1
SCHEMBL9828505 0.67 ADORA3 (0.46) KDM4EHSD17B10ADORA3MEN1KMT2A
SCHEMBL9829223 0.64 MEN1 (0.39) KDM4ENPC1HSD17B10ADORA2AADORA3
SCHEMBL8999792 0.63 KMO (0.59) NPC1HSD17B10MEN1KMT2ARAB9A
SCHEMBL11964123 0.63 RAB9A (0.53) KDM4ENPC1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0233804-B1 MONOARYL-5-AS TRIAZINONES SUBSTITUTED IN POSITION 2, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL PREPARATIONS PIERRE FABRE MEDICAMENT (FR) 1991-09-25 EP claimed